Novel Therapy Lands Speedy Approval for Wart-Like Airway Disease

Summary
(MedPage Today) -- The FDA granted accelerated approval to doruxapapogene ralaplasmid and lalikinogene sifuplasmid (Voceryq) to reduce the frequency of surgical papilloma excisions in adults with recurrent respiratory papillomatosis (RRP), the...
Description from Medpagetoday.
Who is covering this
-
Novel Therapy Lands Speedy Approval for Wart-Like Airway Disease
(MedPage Today) -- The FDA granted accelerated approval to doruxapapogene ralaplasmid and lalikinogene sifuplasmid (Voceryq) to reduce the frequency of surgical papilloma excisions in adults with recurrent respiratory papillomatosis (RRP), the...





Comments
Comments need JavaScript.